Prevalence of corticosteroids use and disease course after initial steroid exposure in ulcerative colitis

Digestive Diseases and Sciences

Volumn 58, Issue 10, 2013, Pages 2963-2969

  Khan, Nabeel ^a,b   Abbas, Ali ^a,b,c   Williamson, Alice ^b   Balart, Luis ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Colectomy; Corticosteroids; Thiopurine; Ulcerative colitis; Veterans Affairs

Indexed keywords

CORTICOSTEROID; MERCAPTOPURINE;

ADULT; ARTICLE; COHORT ANALYSIS; COLON RESECTION; CORTICOSTEROID THERAPY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84885319283     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2748-0     Document Type: Article

References (19)

1. Loftus CG, Loftus EV, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254-261.
2. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol. 1991;26:1247-1256.
3. Kornbluth A, Sachar DB. Gastroenterology PPCotACo. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-523 (quiz 524).
4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041-1048.
5. Ford AC, Bernstein CN, Khan KJ, et al. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:590-599 (quiz 600).
6. Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006;24:319-330.
7. Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260.
8. The National Center for Veterans Analysis and Statistics (NCVAS). Trends in the Utilization of VA Programs and Services. 2012; www.va.gov/vetdata. Accessed 21 April 2012.
9. Khan N, Abbas AM, Almukhtar RM, Khan A. Prevalence and predictors of low bone mineral density in males with ulcerative colitis. J Clin Endocrinol Metab. 2013;98:2368-2375.
10. Garcia-Planella E, Mañosa M, Van Domselaar M, et al. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Dig Liver Dis. 2012;44:206-210.
11. Targownik LE, Singh H, Nugent Z, Bernstein CN. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol. 2012;107:1228-1235.
12. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550.
13. Ha CY, Newberry RD, Stone CD, Ciorba MA. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol. 2010;8:682-687.
14. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
15. Klein RE, Stockford DD. Data on the Socioeconomic Status of Veterans and on VA Program Usage. Office of the Actuary, Veterans Health Administration. 2001; http://www.va.gov/vetdata/docs/SpecialReports/sesprogramnet5-31-01.pdf. Accessed 10 June 2013.
16. Thirumurthi S, Chowdhury R, Richardson P, Abraham NS. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci. 2010;55:2592-2598.
17. Morgan RO, Petersen LA, Hasche JC, et al. VHA pharmacy use in veterans with medicare drug coverage. Am J Manag Care. 2009;15:e1-e8.
18. Wolinsky FD, Miller TR, An H, Brezinski PR, Vaughn TE, Rosenthal GE. Dual use of medicare and the Veterans Health Administration: are there adverse health outcomes? BMC Health Serv Res. 2006;6:131.
19. U.S. Government Accountability Office Report. Veterans Health Care: Use of VA Services by Medicare-Eligible Veterans. 1994; http://www.gao.gov/products/ HEHS-95-13. Accessed 19 February 2013.